Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics.

Devlin AM, Ngai YF, Ronsley R, Panagiotopoulos C.

Transl Psychiatry. 2012 Jan 24;2:e71. doi: 10.1038/tp.2011.68.

2.

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

Stahl SM, Mignon L, Meyer JM.

Acta Psychiatr Scand. 2009 Mar;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x. Review.

PMID:
19178394
3.

Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.

Khandanpour N, Willis G, Meyer FJ, Armon MP, Loke YK, Wright AJ, Finglas PM, Jennings BA.

J Vasc Surg. 2009 Mar;49(3):711-8. doi: 10.1016/j.jvs.2008.10.004. Epub 2009 Jan 21. Review.

4.
5.

Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.

Devlin AM, Panagiotopoulos C.

Pharmacogenomics. 2015;16(9):981-96. doi: 10.2217/pgs.15.55. Epub 2015 Jun 24. Review.

PMID:
26107755
6.

Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate?

Burghardt KJ, Ellingrod VL.

Mol Diagn Ther. 2013 Feb;17(1):21-30. doi: 10.1007/s40291-013-0017-8. Review.

7.

Psoriasis and metabolic syndrome in children: current data.

Pietrzak A, Grywalska E, Walankiewicz M, Lotti T, Roliński J, Myśliński W, Chabros P, Piekarska-Myślińska D, Reich K.

Clin Exp Dermatol. 2017 Mar;42(2):131-136. doi: 10.1111/ced.13014. Epub 2017 Jan 2. Review.

PMID:
28044372
8.

Metabolic syndrome in schizophrenia.

Malhotra N, Grover S, Chakrabarti S, Kulhara P.

Indian J Psychol Med. 2013 Jul;35(3):227-40. doi: 10.4103/0253-7176.119471. Review.

9.

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.

Malan-Müller S, Kilian S, van den Heuvel LL, Bardien S, Asmal L, Warnich L, Emsley RA, Hemmings SM, Seedat S.

Schizophr Res. 2016 Jan;170(1):1-17. doi: 10.1016/j.schres.2015.11.011. Epub 2015 Nov 25. Review.

PMID:
26621002
10.

The genetics of vascular incidents associated with second-generation antipsychotic administration.

Cocchi E, Drago A, de Ronchi D, Serretti A.

Expert Rev Clin Pharmacol. 2014 Jan;7(1):75-90. doi: 10.1586/17512433.2014.865515. Epub 2013 Dec 10. Review.

PMID:
24325740
11.

Genetics of the metabolic syndrome.

Terán-García M, Bouchard C.

Appl Physiol Nutr Metab. 2007 Feb;32(1):89-114. Review.

PMID:
17332787
12.

Nutrigenetics, metabolic syndrome risk and personalized nutrition.

Perez-Martinez P, Phillips CM, Delgado-Lista J, Garcia-Rios A, Lopez-Miranda J, Perez-Jimenez F.

Curr Vasc Pharmacol. 2013 Nov;11(6):946-53. Review.

PMID:
24168447
13.

Attention to medical conditions during mental health clinic visits.

Miller MJ.

Clin Schizophr Relat Psychoses. 2013 Oct;7(3):149-56. doi: 10.3371/CSRP.MI.012513. Review.

PMID:
23367501
14.

The study of psychiatric disease genes and drugs in zebrafish.

Haesemeyer M, Schier AF.

Curr Opin Neurobiol. 2015 Feb;30:122-30. doi: 10.1016/j.conb.2014.12.002. Epub 2014 Dec 16. Review.

Supplemental Content

Support Center